冠状动脉旁路移植术前负荷他汀随机试验
该随机双盲安慰剂对照试验纳入2635例长期他汀治疗的择期孤立CABG患者,术前12小时和2小时给予他汀负荷或安慰剂。改良意向治疗分析(2406例)显示,他汀组与安慰剂组30天内MACCE发生率分别为13.9%和14.9%,差异无统计学意义(OR 0.93,95%CI 0.74-1.18;P=0.562)。
要点
- CABG术前额外负荷他汀未降低30天MACCE发生率。
- 心脏死亡和心梗、心肌损伤及12个月死亡等次要终点组间无差异。
- 长期他汀治疗患者行CABG前不推荐常规负荷他汀。
核心结论
- CABG术前额外负荷他汀未能降低术后30天内MACCE发生率。
主要发现
- 改良意向治疗分析(2406例,每组1203例)显示,他汀组与安慰剂组30天MACCE发生率分别为13.9%和14.9%,OR 0.93(95%CI 0.74-1.18),P=0.562。
- 心脏死亡和心梗复合终点发生率分别为12.1%和13.5%,OR 0.88(95%CI 0.69-1.12),P=0.300。
- 肌钙蛋白T释放曲线下面积中位数分别为0.398和0.394 ng/ml,P=0.333。
- 12个月死亡率分别为3.1%和2.9%,P=0.825。
临床怎么用
- 对于长期他汀治疗的择期孤立CABG患者,术前额外负荷他汀不改善30天MACCE等临床结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Evidence suggests that a high-dose statin loading before a percutaneous coronary revascularization improves outcomes in patients receiving long-term statins. This study aimed to analyse the effects of such an additional statin therapy before surgical revascularization. METHODS AND RESULTS: This investigator-initiated, randomized, double-blind, and placebo-controlled trial was conducted from November 2012 to April 2019 at 14 centres in Germany. Adult patients (n = 2635) with a long-term statin treatment (≥30 days) who were scheduled for isolated coronary artery bypass grafting (CABG) were randomly assigned to receive a statin-loading therapy or placebo at 12 and 2 h prior to surgery using a web-based system. The primary outcome of major adverse cardiac and cerebrovascular events (MACCE) was a composite consisting of all-cause mortality, myocardial infarction (MI), and a cerebrovascular event occuring within 30 days after surgery. Key secondary endpoints included a composite of cardiac death and MI, myocardial injury, and death within 12 months. Non-statistically relevant differences were found in the modified intention-to-treat analysis (2406 patients; 1203 per group) between the statin (13.9%) and placebo groups (14.9%) for the primary outcome [odds ratio (OR) 0.93, 95% confidence interval (CI) 0.74-1.18; P = 0.562] or any of its individual components. Secondary endpoints including cardiac death and MI (12.1% vs. 13.5%; OR 0.88, 95% CI 0.69-1.12; P = 0.300), the area under the troponin T-release curve (median 0.398 vs. 0.394 ng/ml, P = 0.333), and death at 12 months (3.1% vs. 2.9%; P = 0.825) were comparable between treatment arms. CONCLUSION: Additional statin loading before CABG failed to reduce the rate of MACCE occuring within 30 days of surgery.
引用
- Liakopoulos OJ, Kuhn EW, Hellmich M, et al. Statin loading before coronary artery bypass grafting: a randomized trial. Eur Heart J. 2023. PMID: 37086268. doi:10.1093/eurheartj/ehad238
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。